Insight Molecular Diagnostics Inc. (IMDX)

IMDX Revenue

Insight Molecular Diagnostics had revenue of $239.00K in the quarter ending June 30, 2026, a decrease of -53.86%. This brings the company's total for the last twelve months to $1.67M, down -60.77% year-over-year. In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.06M with 115.58% growth. That makes Insight Molecular Diagnostics the 42,738th largest company in the world by revenue and 5,868th in the United States.

• Revenue (ttm): $1.67M
• Revenue Growth: -60.77%
• P/S Ratio: 58.00
• Revenue / Employee: $28,793
• Employees: 58
• Market Cap: 96.86M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 4.03M 99.4%
• Europe 24.00K 0.6%

Fiscal year ended Dec 31, 2025 See the full IMDX breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.06M	2.17M	115.58%
Dec 31, 2024	1.88M	378.00K	25.15%
Dec 31, 2023	1.50M	545.00K	56.89%
Dec 31, 2022	958.00K	-1.24M	-56.41%
Dec 31, 2021	2.20M	982.00K	80.76%
Dec 31, 2020	1.22M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error